Post-earnings recap
Reported
Fri, Jan 31, 2025
EPS actual
$1.98
EPS est.
$1.81
EPS surprise
+9.63%
1-day move
-0.03%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
This earnings report shows that Novartis was able to exceed EPS expectations, which is a positive sign for the company's profitability. However, the stock reacted slightly negatively, down 0.03%, indicating that investors may have been looking for more detailed revenue insights or future guidance. The lack of guidance could lead to uncertainty among investors moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.98 | N/A | +9.63% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. However, they did not provide specific guidance for the upcoming quarters.
We are pleased with our EPS performance this quarter.
Our focus remains on innovation and pipeline development.